SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-002845
Filing Date
2004-05-27
Accepted
2004-05-27 15:02:28
Documents
3
Period of Report
2004-05-21
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b50688aie8vk.txt 8-K 3201
2 RIGHT OF FIRST REFUSAL AGREEMENT b50688aiexv4w1.txt EX-4.1 34095
3 AMEND. NO.2 TO 1999 EQUITY INCENTIVE PLAN b50688aiexv10w1.txt EX-10.1 19630
  Complete submission text file 0000950135-04-002845.txt   58797
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 04834832
SIC: 2836 Biological Products, (No Diagnostic Substances)